SERAFs grant from the Research Council of Norway enables SERAF to perform clinical addiction research at an international level and contributes to a more sufficient, evidence-based treatment of addiction disorders.
To meet the request from the research council we have significantly increased our alcohol research. We conduct extensive dissemination of addiction research through publications, lectures, courses, supervision and teaching of master and PhD students.
SERAF has a broad national and international network in the field of clinical addiction research.
1,000 answered a patient survey of opioid maintenance treatment
Apr. 5, 2018 1:18 PM
SERAF and ProLAR have published the first scientific article that reports patient satisfaction and side effects of all three OMT medications, from a survey answered by more than 1,000 patients. ProLAR designed and implemented the survey, and SERAF helped analyze the data.
Half of substance users have recently been victims of crime
Nov. 16, 2017 1:18 PM
Victimization was associated with symptoms of poor mental health, more serious substance use and unstable housing.
Extended-release naltrexone as effective as buprenorphine-naloxone on retention in treatment and reducing use of heroin and other Illicit opioids in head-to-head comparison trial
Oct. 20, 2017 11:57 AM
In the 12-week, open-label, randomized-controlled study, 159 patients with opioid dependence were randomized to treatment with either extended-release naltrexone or buprenorphine-naloxone, following detoxification.
- Stimulant medication for ADHD in opioid maintenance treatment Dec. 1, 2014 12:02 PM
- From methadone to buprenorphine: Changes during a 10 year period within a national opioid maintenance treatment programme Sep. 18, 2014 3:33 PM
- Motivational intervention to enhance post-detoxification 12-Step group affiliation: a randomized controlled trial Sep. 18, 2014 3:24 PM